Therapeutic Asset Ratings

6,308 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Tq-B3525 Non-Small Cell Lung Carcinoma	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	P1/2	CCC (48)
Transcon Il-2 Β/Γ Cervical Cancer	Ascendis Pharma Oncology Division A/S	P1/2	CCC (48)
Transcon Il-2 Β/Γ Non-Small Cell Lung Carcinoma	Ascendis Pharma Oncology Division A/S	P1/2	CCC (48)
Transcon Il-2 Β/Γ Small Cell Lung Carcinoma	Ascendis Pharma Oncology Division A/S	P1/2	CCC (48)
Transcon Il-2 Β/Γ HER2 Positive Breast Carcinoma	Ascendis Pharma Oncology Division A/S	P1/2	CCC (48)
Transcon Tlr7/8 Agonist Cervical Cancer	Ascendis Pharma Oncology Division A/S	P1/2	CCC (48)
Transcon Tlr7/8 Agonist Melanoma	Ascendis Pharma Oncology Division A/S	P1/2	CCC (48)
Transcon Tlr7/8 Agonist Non-Small Cell Lung Carcinoma	Ascendis Pharma Oncology Division A/S	P1/2	CCC (48)
Transcon Tlr7/8 Agonist Small Cell Lung Carcinoma	Ascendis Pharma Oncology Division A/S	P1/2	CCC (48)
Transcon Tlr7/8 Agonist HER2 Positive Breast Carcinoma	Ascendis Pharma Oncology Division A/S	P1/2	CCC (48)
Trastuzumab Central Nervous System Neoplasm	Memorial Sloan Kettering Cancer Center	P1/2	CCC (48)
Trastuzumab Central Nervous System Disorder	Reva Basho	P1/2	CCC (48)
Trastuzumab Sarcoma	OHSU Knight Cancer Institute	P1/2	CCC (48)
Trastuzumab Emtansine Cervical Cancer	Ascendis Pharma Oncology Division A/S	P1/2	CCC (48)
Trastuzumab Emtansine Small Cell Lung Carcinoma	Ascendis Pharma Oncology Division A/S	P1/2	CCC (48)
Treg Cells Acute Leukemia	Stanford University	P1/2	CCC (48)
Tri-611 Non-Small Cell Lung Carcinoma	TRIANA Biomedicines, Inc.	P1/2	CCC (48)
Trifluridine Adamantinous Craniopharyngioma	Parabilis Medicines, Inc.	P1/2	CCC (48)
Trifluridine Desmoid Tumor	Parabilis Medicines, Inc.	P1/2	CCC (48)
Trifluridine Endometrial Carcinoma	Parabilis Medicines, Inc.	P1/2	CCC (48)
Trifluridine Cholangiocarcinoma	Emory University	P1/2	CCC (48)
Trifluridine Gastric Cancer	Emory University	P1/2	CCC (48)
Trifluridine Malignant Pancreatic Neoplasm	Emory University	P1/2	CCC (48)
Trifluridine Digestive System Carcinoma	Emory University	P1/2	CCC (48)
Trifluridine Exocrine Pancreatic Carcinoma	Emory University	P1/2	CCC (48)

Showing 1951 to 1975 of 6,308 assets

PreviousPage 79 of 253Next